|
|
| ANNUAL MEETING UPDATE- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Register now for Annual Meeting
 Registration is now open for the 20th NAMS Annual Meeting, scheduled for September 30 - October 3 in San Diego, California. The Program, registration details, and
hotel reservation information are posted on the NAMS Web site. Register before July 31 to receive the lowest registration fee. Don't miss this year's valuable offerings!
Timely advice available at Annual Meeting
This year's meeting offers clinically relevant sessions addressing
sexual function, breast cancer, hot flashes, vaginal and vulvar health, osteoporosis, urinary disorders, autoimmune disorders, HT, SERMs, and more -- plus practice-related sessions such as how to improve your menopause management business. And the 35 roundtable sessions give you a special opportunity to have your questions addressed. Don't miss this year's meeting!
Arrive early for pre-meeting symposium
An exciting half-day pre-meeting symposium addresses "Depressive Symptoms and Cognitive Complaints in the Menopausal Transition."
Arrive on Tuesday, September 29, for the symposium that's scheduled
for 8:00 AM to 1:50 PM on Wednesday, September 30. Separate registration from the Annual Meeting is required.
| EDUCATION MATTERS - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Learn more about SERMs through EMPREss
NAMS now offers, along with Penn State Medical College and
Indicia Medical Education, a new provider education initiative called "EMPREss: Enhancing Menopause management through understanding the Physiology of Receptors of Estrogen," consisting of case consults, an interactive estrogen receptor (ER) challenge, and news summaries focused on integrating menopause-related patient care with a better understanding of the mechanisms and effects of estrogen and other ER ligands such as selective estrogen-receptor modulators (SERMs). Take a look at the first CME component of this initiative, Multiperspective Case Consult #1, in which an ob/gyn, an internist, and an endocrinologist comment on a single patient with severe symptoms.
Clinician-patient videos bring
scientific information to life
Here's the latest NAMS/Medscape educational collaboration to enhance your menopause management skills. Called "Dialogues in Menopause Management: Counseling Postmenopausal Women About Initiating Estrogen Use for Severe Vasomotor Symptoms and Osteoporosis Prevention," this interactive Test & Teach CME activity features a videotaped vignette between Dr. Steven R. Goldstein and a "patient."
Osteoporosis drugs chart updated
NAMS has updated its helpful chart featuring all drugs approved in
the United States and Canada for prevention and/or treatment of postmenopausal osteoporosis. It's available without charge on the
NAMS Web site.
| PATIENT EDUCATION - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Menopause Awareness Month
Coming soon is an opportunity to step up your menopause-focused
patient education. NAMS offers top-notch educational materials to help. September is the official Menopause Awareness Month in the United States; October is World Menopause Month as recently declared by
the IMS.
NAMS no longer associated with Changes magazine
NAMS once provided editorial oversight, and hence content credibility, for this consumer magazine distributed annually through healthcare providers' offices. Because the publisher materially breached its contract with NAMS, the Society is no longer involved, beginning with the 2009 issue.
| COMPETENCY EXAM NEWS - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
New NCMPs announced  |
Congratulations to the 39 licensed healthcare providers who earned the credential of NAMS Certified Menopause Practitioner (NCMP) on May 16, 2009.
|
| UTIAN TRIBUTE EVENTS - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Pay tribute to Dr. Utian and his work
 Dr. Wulf Utian, NAMS Founder and Executive Director,
retires from NAMS at year's end. Pay tribute to his work
by attending one or more of the three tribute events:
the September 30 (4:40-6:15 PM) session at the
San Diego Annual Meeting and two October 24 Cleveland events, a morning Consumer Education Event and a
Gala "Tribute to Wulf Utian" that evening. You may also want to place your own personal tribute message in one or all three of the keepsake Programs. Fees begin at $25 for a name listing. The extended deadline is August 15. Contact Angela Bilancini or go to the NAMS Web site.
| SOCIETY BUSINESS - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
2008 Annual Report available
Check out last year's many accomplishments in our Annual Report. Our 2008 supporters are also listed – thank you!
Frederick P. Zuspan, MD: In memoriam
We are saddened to learn that Dr. Zuspan, a distinguished
obstetrician-gynecologist, Editor Emeritus of The American Journal of Obstetrics & Gynecology, and longtime NAMS member, succumbed on June 7 at the age of 87 to prostatic cancer.
| FUNDRAISING UPDATE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Support our work with your gifts
 "I feel very proud that NAMS has come so far
in 20 years and is helping so many," said
Dr. Wulf Utian. "How can you feel as good as I do? One way is to support the NAMS Foundation Annual Fund. Your tax-deductible gift will allow us to continue to enhance our services to women in search of unbiased information. Empowered with good information, they can make informed healthcare decisions around the time of menopause that will affect their health and quality of life now and for years to come."
| MENOPAUSE THERAPY NEWS - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
NAMS Spotlight on New Therapies
By popular request, NAMS provides ongoing
information regarding new therapeutic options in menopause management. Note, however, that this
mention does not imply endorsement. Click to see
this month's highlights.
|
